Cogent Biosciences, Inc. — Director's Dealing 2020

Oct 15, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cogent Biosciences, Inc. (COGT)
CIK: 0001622229
Period of Report: 2020-10-13

Reporting Person: Green John L. (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-13	Stock Option (Right to Buy)	$2.89	A	695700	Acquired	2030-10-12	Common Stock (695700)	Direct

Footnotes

F1: This stock option shall vest as follows: 25% on the first anniversary of the date of grant then in equal monthly installments over 36 months.